Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
Author:
Funder
National Institute of Allergy and Infectious Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference144 articles.
1. Asthma-associated risk for COVID-19 development;Skevaki;J Allergy Clin Immunol,2020
2. Integrated-omics endotyping of infants with rhinovirus bronchiolitis and risk of childhood asthma;Raita;J Allergy Clin Immunol,2021
3. Asthma and viruses: a focus on rhinoviruses and SARS-CoV-2;Padayachee;J Allergy Clin Immunol,2021
4. Advances in asthma: new understandings of asthma’s natural history, risk factors, underlying mechanisms, and clinical management;Miller;J Allergy Clin Immunol,2021
5. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan;Li;J Allergy Clin Immunol,2020
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of COVID-19 infection in pediatric and adult patients with primary immunodeficiency: a single center analysis;LymphoSign Journal;2024-01-11
2. Toxicity assessment of SARS-CoV-2-derived peptides in combination with a mix of pollutants on zebrafish adults: A perspective study of behavioral, biometric, mutagenic, and biochemical toxicity;Science of The Total Environment;2023-02
3. Chromogranin A plasma levels predict mortality in COVID-19;PLOS ONE;2022-04-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3